We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Latvia's drug wholesalers have reported turnover of US$187mn for the first half of the year, driven by soaring medicine consumption and relatively high wholesaler/pharmacy mark-ups, which average 13%.
Vietnam and Indonesia have agreed to increase bilateral co-operation for healthcare services, drug production and in the fight against infectious diseases.
American Oriental Bioengineering Inc. (AMEX: AOB), an emerging Chinese company that produces and distributes a broad range of pharmaceutical and nutraceutical products, announced that on Sept. 22, 2005, the company delivered a redemption notice with respect to all of its Class B warrants, and as of Oct. 12, all 3 million Class B warrants had been exercised.
LAB International Inc. (TSX: LAB, Frankfurt: LD9.F, XETRA: LD9.DE) ("LAB"), an integrated drug development company with subsidiaries focused on developing therapies for the inhalation market and on providing contract research services, today announced that it has entered into a sale and leaseback transaction with Woodcliffe Corporation.
Schering AG, Germany's third-largest drugmaker, stopped a trial of its Asoprisnil treatment for benign uterine growths after some patients developed side effects that required surgery to reverse.
Peplin Limited (ASX:PEP) announced today that it had commenced the construction of a new commercial scale manufacturing facility for the production of GMP (Good Manufacturing Practice) grade PEP005, its lead investigational agent being developed to treat skin cancer and leukemia.